Generalised anxiety disorder research hub
3 indexed studies · 3 currently recruiting
- recruitingPhase II
A clinical trial of 5 mg psilocybin plus psychological support vs 25 mg psilocybin plus psychological support in adults with generalised anxiety disorder
This UK clinical trial is testing whether psilocybin, combined with talking therapy, can help adults with generalised anxiety disorder. Researchers are comparing a lower dose (5 mg) against a higher dose (25 mg) to see which is more effective and safe at reducing moderate to severe anxiety symptoms.
United Kingdom - recruitingPhase II and Phase III (Integrated)
A Phase 2/3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP 363856 in the Treatment of Adults with Generalized Anxiety Disorder
This study is looking at a new medicine called Ulotaront for adults with generalised anxiety disorder. We want to see if it helps reduce anxiety and if it's safe to use. Some people will get the new medicine, and others will get a dummy pill.
Estonia · Spain · Finland - recruiting
CBT and the Neural Circuits of Anxiety
This study looks at how a talking therapy called CBT changes the brain in people with anxiety. It aims to understand why CBT works, hoping to make treatments even better and more personal for anxiety in the future.
United Kingdom